|
RRAGB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81410442223751E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02271532856457E-12 |
| Normal-vs-Stage2 |
1.65873999999899E-05 |
| Normal-vs-Stage3 |
5.12919995365735E-09 |
| Normal-vs-Stage4 |
1.35890187991095E-11 |
| Stage1-vs-Stage2 |
5.825000E-01 |
| Stage1-vs-Stage3 |
6.354400E-01 |
| Stage1-vs-Stage4 |
1.923980E-02 |
| Stage2-vs-Stage3 |
4.675000E-01 |
| Stage2-vs-Stage4 |
5.137700E-02 |
| Stage3-vs-Stage4 |
1.302630E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.44995127016045E-13 |
| Normal-vs-AfricanAmerican |
4.698300E-03 |
| Normal-vs-Asian |
1.38599999999212E-06 |
| Caucasian-vs-AfricanAmerican |
7.942400E-02 |
| Caucasian-vs-Asian |
4.522800E-01 |
| AfricanAmerican-vs-Asian |
3.163600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.41999745295607E-11 |
| Normal-vs-Female |
5.59996493620929E-12 |
| Male-vs-Female |
6.569000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.0951019525105E-11 |
| Normal-vs-Age(41-60Yrs) |
7.01779745426734E-11 |
| Normal-vs-Age(61-80Yrs) |
5.94630000794183E-09 |
| Normal-vs-Age(81-100Yrs) |
4.418700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.116600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.969600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.924000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.555800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.593800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.771000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.397000E-03 |
| Classical-VS-Follicular |
7.055000E-01 |
| Classical-VS-Other |
9.446400E-01 |
| Classical-VS-Normal |
2.94489987950897E-11 |
| Tall-VS-Follicular |
3.846400E-02 |
| Tall-VS-Other |
2.005800E-01 |
| Tall-VS-Normal |
1.03310027199655E-10 |
| Follicular-VS-Other |
9.584200E-01 |
| Follicular-VS-Normal |
1.06350000028677E-07 |
| Other-VS-Normal |
1.522220E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.66430236048632E-11 |
| Normal-vs-N1 |
1.21940002539844E-09 |
| N0-vs-N1 |
1.097800E-01 |
|
|
